The director of external relations for Procter & Gamble, Mark Chakravarty, recently told a UK healthcare PR conference that the drug industry is less than popular with the public. "There is a high suspicion of the pharma industry. Greed, dishonesty and fraud are some of its associations. The clinical trial press this week and an increased number of drug scandals add to this image," he said.Quite, Procter and Gamble.
I'm less worried about the "greed". Commercial companies don't need to apologise for generating money from honest science and real innovation. Let's concentrate on the lies and the fraud, and more importantly on the collusion with government and "regulators" to hide evidence, to excuse bad science and to escape responsibility. Why not give me a call Mr Chakravarty? Effective public relations requires working with critics, admitting faults and correcting them.
Labels: Procter and Gamble